NDC00469-3770-25: DEXTROSE INJECTION.
The DEXTROSE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, special_features: NONBACTERIOSTATIC, primary_container_type: VIAL, secondary_container_type: PACKAGE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 100. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-247-9167, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | NONBACTERIOSTATIC |
| primary_container_type | VIAL |
| secondary_container_type | PACKAGE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 100 |
| primary_container_content_quantity | 50.000 MILLILITERS |
| total_secondary_container_quantity | 2 |
| active_medicament_medicinal_strength | 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| primary_container_quantity_per_secondary_container | 25 VIAL |
| NSN | 6505-01-247-9167 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| SECONDARY CONTAINER TYPE | PACKAGE |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | NONBACTERIOSTATIC |
| TOTAL SECONDARY CONTAINER QUANTITY | 2 |
| PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 25 VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 100 |